GALE logo

Galenica AG Stock Price

SWX:GALE Community·CHF 4.3b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

GALE Share Price Performance

CHF 86.15
9.50 (12.39%)
0.8% overvalued intrinsic discount
CHF 85.50
Fair Value
CHF 86.15
9.50 (12.39%)
0.8% overvalued intrinsic discount
CHF 85.50
Fair Value
Price CHF 86.15
AnalystConsensusTarget CHF 85.50

GALE Community Narratives

AnalystConsensusTarget·
Fair Value CHF 85.5 0.8% overvalued intrinsic discount

GALE: Stable Outlook As Digital And In-Store Investments Will Support 2025 Guidance

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
3 Rewards

Galenica AG Key Details

CHF 4.0b

Revenue

CHF 3.5b

Cost of Revenue

CHF 482.4m

Gross Profit

CHF 290.0m

Other Expenses

CHF 192.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 10, 2026
3.86
11.98%
4.78%
41.6%
View Full Analysis

About GALE

Founded
1927
Employees
7991
CEO
Marc Werner
WebsiteView website
www.galenica.com

Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates in two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at home; and develops, markets, and sells healthcare services and products through various distribution channels. The Logistics & IT segment provides various specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data system for the healthcare market; develops management solutions for the healthcare market; provides group internal IT services; distributes the former Viatris OTC products; and publishes printed and electronic technical information on pharmaceutical products, as well as offers complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Recent GALE News & Updates

Here's Why We Think Galenica (VTX:GALE) Is Well Worth Watching

Nov 05
Here's Why We Think Galenica (VTX:GALE) Is Well Worth Watching

Recent updates

No updates